Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
Immunostimulatory therapies targeting immune-suppressive pathways produce durable responses in advanced solid tumors. Indoleamine 2,3-dioxygenase (IDO) is the rate-limiting oxidoreductase that catalyzes the de...
Journal for ImmunoTherapy of Cancer 2017 5:81
Published on: 17 October 2017